Pragmatic Solutions for Immuno-Oncology Programs
-
Upload
covance -
Category
Health & Medicine
-
view
221 -
download
0
Transcript of Pragmatic Solutions for Immuno-Oncology Programs
Public
Copyright © 2015 Covance. All Rights Reserved
PRAGMATIC SOLUTIONS FOR
IMMUNO-ONCOLOGY PROGRAMS
Frank Makosiej, Jr., PharmDExecutive Director, Operational Strategy & Planning,Oncology
Public
Objectives
Exponential increase in the number of trials evaluating immuno-oncology treatment options
Immuno-oncology trials are different and require an enhanced skill set from all parties involved in a clinical trial
Choosing the right country and site for successful trial execution is a critical step in the entire drug development program
Leveraging historical data to better predict more efficient and scalable ways to recruit patients for clinical trials has been the focal point for the biopharmaceutical industry
How to utilize a historical data-driven methodology to pin-point specific investigators who are consistently excellent performers to ensure trial success. The importance of a quality knowledgebase and data breadth will also be discussed.
Boston Oncology Leader's Forum2
Public
Key Messages
Model:
Agile,
Scalable
Method:
Site-Centric
Quality-Focused
Value Add:
Support a Changing Immuno-Oncology
Portfolio
Success:
Productivity and Efficiency Gains
Boston Oncology Leader's Forum3
Public
Immune-related toxicities (irAE)
Response criteria (irRC)
Duration of treatment
(maintenance?, retreatment upon
progression)
Biomarkers (predictors of
response)
Combination treatment
Tumor types
Characteristics of Immunotherapy
Boston Oncology Leader's Forum4
Public
Characteristics of Immunotherapy
Mandate Informed Insights
Increasing
Combination
Treatments
Immuno-
Oncology
Immune-
Related
Response
Criteria
irRC
Duration of
Treatment
Biomarkers
Predictors of
Response
Broadening
Tumor Types
Immune-
Related
Toxicities
irAEs
Boston Oncology Leader's Forum5
Public
Xcellerate® Informatics Technology Platform
Solutions Provide Informed Insights
Interactive Demonstration
Boston Oncology Leader's Forum6
Covance Inc., headquartered in Princeton, NJ, is the drug development business of Laboratory Corporation of America® Holdings
(LabCorp®). Covance is the marketing name for Covance Inc. and its subsidiaries around the world. © Copyright 2015. Covance Inc.